Mer­ck KGaA hands off its CAR-T R&D op­er­a­tions to In­trex­on in $175M deal

Mer­ck KGaA is bow­ing out of the CAR-T de­vel­op­ment busi­ness, hand­ing over its rights to In­trex­on $XON in ex­change for $150 mil­lion batch of stock …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.